Action 300511 SHANGHAI XUERONG BIOTECHNOLOGY CO.,LTD.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Shanghai Xuerong Biotechnology Co.,Ltd.

Actions

300511

CNE100002706

Cours en clôture Shenzhen S.E.
Autres places de cotation
 00:00:00 29/04/2024 		Varia. 5j. Varia. 1 janv.
3,59 CNY +4,06% Graphique intraday de Shanghai Xuerong Biotechnology Co.,Ltd. +13,25% -32,90%
25/04 Shanghai Xuerong Biotechnology Co. annonce ses résultats pour le premier trimestre clos le 31 mars 2024 CI
2023 Shanghai Xuerong Biotechnology Co. publie ses résultats pour la période de neuf mois se terminant le 30 septembre 2023 CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Shanghai Xuerong Biotechnology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
Shanghai Xuerong Biotechnology Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
Shanghai Xuerong Biotechnology Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
Shanghai Xuerong Biotechnology Co.,Ltd. Approves Board Appointments
Shanghai Xuerong Biotechnology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
Shanghai Xuerong Biotechnology Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
Shanghai Xuerong Biotechnology Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
Shanghai Xuerong Biotechnology Co.,Ltd. Approves By-Election of Directors
Shanghai Xuerong Biotechnology Co.,Ltd. Announces Final Cash Dividend Proposal for 2021
Shanghai Xuerong Biotechnology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
Shanghai Xuerong Biotechnology Co.,Ltd. announced that it has received CNY 397.999996 million in funding
Yinwan Huayi No. 1 Private Securities Investment Fund managed by Zhejiang Invest Equity Investment & Management Co., Ltd. agreed to acquire 5% stake in Shanghai Xuerong Biotechnology Co.,Ltd. from Yang Yongping for CNY134 million.
Shanghai Xuerong Biotechnology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021
Shanghai Xuerong Biotechnology Co.,Ltd. Announces to Implement Final Cash Distribution Plan for 2020, Payable on 14 May 2021
Shanghai Xuerong Biotechnology Co., Ltd. Approves Cash Dividend for the Year 2020
Shanghai Xuerong Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021
Shanghai Xuerong Biotechnology Co., Ltd. Announces Final Cash Dividend for the Year 2020
Shanghai Xuerong Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020
Shanghai Juhui Biopharmaceutical Industrial Development Co., Ltd. entered into a share transfer agreement to acquire Shanghai Gaorong Biotechnology Co., Ltd. from Shanghai Xuerong Biotechnology Co., Ltd. and Shanghai Xuerong Edible Fungus Co., Ltd for CNY 78 million.
Shanghai Xuerong Biotechnology Co., Ltd. announced that it expects to receive CNY 2.25 billion in funding
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action 300511
  4. Actualités Shanghai Xuerong Biotechnology Co.,Ltd.
  5. Autres langues